{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:43:47Z","timestamp":1773798227660,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T00:00:00Z","timestamp":1691971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR19115\/MED\/122\/11\/2016"],"award-info":[{"award-number":["BT\/PR19115\/MED\/122\/11\/2016"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s13760-023-02352-5","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T16:02:11Z","timestamp":1692028931000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quantitative susceptibility mapping from basal ganglia and related structures: correlation with disease severity in progressive supranuclear palsy"],"prefix":"10.1007","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2889-2771","authenticated-orcid":false,"given":"Syam","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha Susan","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vineeth","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheelakumari","family":"Raghavan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bejoy","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jissa Vinoda","family":"Thulaseedharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya Kalikavil","family":"Puthenveedu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,14]]},"reference":[{"issue":"1","key":"2352_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47(1):1\u20139. https:\/\/doi.org\/10.1212\/WNL.47.1.1","journal-title":"Neurology"},{"issue":"2","key":"2352_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/s-0034-1381736","volume":"34","author":"LI Golbe","year":"2014","unstructured":"Golbe LI (2014) Progressive supranuclear palsy. Semin Neurol 34(2):151\u2013159. https:\/\/doi.org\/10.1055\/s-0034-1381736","journal-title":"Semin Neurol"},{"issue":"3","key":"2352_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11910-018-0819-5","volume":"18","author":"MJ Armstrong","year":"2018","unstructured":"Armstrong MJ (2018) Progressive supranuclear palsy: an update. Curr Neurol Neurosci Rep 18(3):12. https:\/\/doi.org\/10.1007\/s11910-018-0819-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2352_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.irn.2019.10.013","volume":"149","author":"N Giagkou","year":"2019","unstructured":"Giagkou N, H\u00f6glinger GU, Stamelou M (2019) Progressive supranuclear palsy. Int Rev Neurobiol 149:49\u201386. https:\/\/doi.org\/10.1016\/bs.irn.2019.10.013","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"2352_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE et al (2017) Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov Disord 32(6):853\u2013864. https:\/\/doi.org\/10.1002\/mds.26987","journal-title":"Mov Disord"},{"issue":"5 Suppl 1","key":"2352_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1590\/0004-282x-anp-2022-s134","volume":"80","author":"JB Parmera","year":"2022","unstructured":"Parmera JB, Oliveira MCB, Rodrigues RD, Coutinho AM (2022) Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers. Arq Neuropsiquiatr 80(5 Suppl 1):126\u2013136. https:\/\/doi.org\/10.1590\/0004-282x-anp-2022-s134","journal-title":"Arq Neuropsiquiatr"},{"issue":"7","key":"2352_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/s1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, H\u00f6glinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552\u2013563. https:\/\/doi.org\/10.1016\/s1474-4422(17)30157-6","journal-title":"Lancet Neurol"},{"key":"2352_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/jnnp-2017-315857","volume":"88","author":"E Jabbari","year":"2017","unstructured":"Jabbari E, Zetterberg H, Morris HR (2017) Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers. J Neurol Neurosurg Psychiatr 88:883\u2013888. https:\/\/doi.org\/10.1136\/jnnp-2017-315857","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"10","key":"2352_CR9","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1474-4422(14)70117-6","volume":"13","author":"RJ Ward","year":"2014","unstructured":"Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L (2014) The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 13(10):1045\u20131060. https:\/\/doi.org\/10.1016\/s1474-4422(14)70117-6","journal-title":"Lancet Neurol"},{"issue":"4","key":"2352_CR10","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","volume":"114","author":"DT Dexter","year":"1991","unstructured":"Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE et al (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114(4):1953\u20131975. https:\/\/doi.org\/10.1093\/brain\/114.4.1953","journal-title":"Brain"},{"issue":"4","key":"2352_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jmri.20404","volume":"22","author":"V Sehgal","year":"2005","unstructured":"Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK et al (2005) Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 22(4):439\u2013450. https:\/\/doi.org\/10.1002\/jmri.20404","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"2352_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00234-010-0677-6","volume":"52","author":"D Gupta","year":"2010","unstructured":"Gupta D, Saini J, Kesavadas C, Sarma PS, Kishore A (2010) Utility of susceptibility-weighted MRI in differentiating Parkinson\u2019s disease and atypical parkinsonism. Neuroradiology 52(12):1087\u20131094. https:\/\/doi.org\/10.1007\/s00234-010-0677-6","journal-title":"Neuroradiology"},{"issue":"1","key":"2352_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mri.2014.09.004","volume":"33","author":"EM Haacke","year":"2015","unstructured":"Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y (2015) Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging 33(1):1\u201325. https:\/\/doi.org\/10.1016\/j.mri.2014.09.004","journal-title":"Magn Reson Imaging"},{"key":"2352_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.3668","author":"S Eskreis-Winkler","year":"2017","unstructured":"Eskreis-Winkler S, Zhang Y, Zhang J, Liu Z, Dimov A, Gupta A et al (2017) The clinical utility of QSM: disease diagnosis, medical management, and surgical planning. NMR Biomed. https:\/\/doi.org\/10.1002\/nbm.3668","journal-title":"NMR Biomed"},{"issue":"2","key":"2352_CR15","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3174\/ajnr.a4524","volume":"37","author":"R Sheelakumari","year":"2016","unstructured":"Sheelakumari R, Madhusoodanan M, Radhakrishnan A, Ranjith G, Thomas B (2016) A potential biomarker in amyotrophic lateral sclerosis: can assessment of brain iron deposition with swi and corticospinal tract degeneration with DTI Help? Am J Neuroradiol 37(2):252\u2013258. https:\/\/doi.org\/10.3174\/ajnr.a4524","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"2352_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.neuroimage.2012.05.049","volume":"62","author":"C Langkammer","year":"2012","unstructured":"Langkammer C, Schweser F, Krebs N, Deistung A, Goessler W, Scheurer E et al (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post-mortem validation study. Neuroimage 62(3):1593\u20131599. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.05.049","journal-title":"Neuroimage"},{"key":"2352_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.parkreldis.2017.08.029","volume":"44","author":"H Sj\u00f6str\u00f6m","year":"2017","unstructured":"Sj\u00f6str\u00f6m H, Granberg T, Westman E, Svenningsson P (2017) Quantitative susceptibility mapping differentiates between Parkinsonian disorders. Parkinsonism Relat Disord 44:51\u201357. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.029","journal-title":"Parkinsonism Relat Disord"},{"key":"2352_CR18","doi-asserted-by":"publisher","first-page":"101999","DOI":"10.1016\/j.nicl.2019.101999","volume":"24","author":"S Mazzucchi","year":"2019","unstructured":"Mazzucchi S, Frosini D, Costagli M, Del Prete E, Donatelli G, Cecchi P et al (2019) Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin 24:101999. https:\/\/doi.org\/10.1016\/j.nicl.2019.101999","journal-title":"Neuroimage Clin"},{"issue":"1","key":"2352_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3174\/ajnr.a0770","volume":"29","author":"SL Harder","year":"2008","unstructured":"Harder SL, Hopp KM, Ward H, Neglio H, Gitlin J, Kido D (2008) Mineralization of the deep gray matter with age: a retrospective review with susceptibility-weighted MR imaging. Am J Neuroradiol 29(1):176\u2013183. https:\/\/doi.org\/10.3174\/ajnr.a0770","journal-title":"Am J Neuroradiol"},{"issue":"3","key":"2352_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55(3):181\u2013184. https:\/\/doi.org\/10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"12","key":"2352_CR21","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"9","key":"2352_CR22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1002\/mds.20513","volume":"20","author":"GA Kang","year":"2005","unstructured":"Kang GA, Bronstein JM, Masterman DL, Redelings M, Crum JA, Ritz B (2005) Clinical characteristics in early Parkinson\u2019s disease in a central California population-based study. Mov Disord 20(9):1133\u20131142. https:\/\/doi.org\/10.1002\/mds.20513","journal-title":"Mov Disord"},{"issue":"6","key":"2352_CR23","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/brain\/awm032","volume":"130","author":"LI Golbe","year":"2007","unstructured":"Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130(6):1552\u20131565. https:\/\/doi.org\/10.1093\/brain\/awm032","journal-title":"Brain"},{"issue":"1","key":"2352_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/mds.870090112","volume":"9","author":"P Mart\u00ednez-Mart\u00edn","year":"1994","unstructured":"Mart\u00ednez-Mart\u00edn P, Gil-Nagel A, Gracia LM, G\u00f3mez JB, Mart\u00ednez-Sarri\u00e9s J, Bermejo F (1994) Unified Parkinson\u2019s disease rating scale characteristics and structure. The cooperative multicentric group. Mov Disord 9(1):76\u201383. https:\/\/doi.org\/10.1002\/mds.870090112","journal-title":"Mov Disord"},{"issue":"1","key":"2352_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mds.870070103","volume":"7","author":"JW Langston","year":"1992","unstructured":"Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T et al (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7(1):2\u201313. https:\/\/doi.org\/10.1002\/mds.870070103","journal-title":"Mov Disord"},{"issue":"1","key":"2352_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0028-3886.173663","volume":"64","author":"S Krishnan","year":"2016","unstructured":"Krishnan S, Prasad S, Pisharady KK, Sarma G, Sarma SP, Kishore A (2016) The decade after subthalamic stimulation in advanced Parkinson\u2019s disease: a balancing act. Neurol India 64(1):81\u201389. https:\/\/doi.org\/10.4103\/0028-3886.173663","journal-title":"Neurol India"},{"issue":"1","key":"2352_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27058","volume":"53","author":"S Vinayagamani","year":"2020","unstructured":"Vinayagamani S, Sheelakumari R, Sabarish S, Senthilvelan S, Ros R, Thomas B et al (2020) Quantitative susceptibility mapping: technical considerations and clinical applications in neuroimaging. J Magn Reson Imaging 53(1):23\u201337. https:\/\/doi.org\/10.1002\/jmri.27058","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"2352_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17(3):143\u2013155. https:\/\/doi.org\/10.1002\/hbm.10062","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"2352_CR29","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31(3):1116\u20131128. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.01.015","journal-title":"Neuroimage"},{"issue":"9","key":"2352_CR30","doi-asserted-by":"publisher","first-page":"e0162460","DOI":"10.1371\/journal.pone.0162460","volume":"11","author":"C Langkammer","year":"2016","unstructured":"Langkammer C, Pirpamer L, Seiler S, Deistung A, Schweser F, Franthal S et al (2016) Quantitative susceptibility mapping in Parkinson\u2019s disease. PloS One 11(9):e0162460. https:\/\/doi.org\/10.1371\/journal.pone.0162460","journal-title":"PloS\u00a0One"},{"issue":"8","key":"2352_CR31","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00234-017-1870-7","volume":"59","author":"K Ito","year":"2017","unstructured":"Ito K, Ohtsuka C, Yoshioka K, Kameda H, Yokosawa S, Sato R et al (2017) Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping. Neuroradiology 59(8):759\u2013769. https:\/\/doi.org\/10.1007\/s00234-017-1870-7","journal-title":"Neuroradiology"},{"key":"2352_CR32","doi-asserted-by":"publisher","first-page":"109394","DOI":"10.1016\/j.ejrad.2020.109394","volume":"133","author":"MP Fedeli","year":"2020","unstructured":"Fedeli MP, Contarino VE, Siggillino S, Samoylova N, Calloni S, Melazzini L et al (2020) Iron deposition in Parkinsonisms: a quantitative susceptibility mapping study in the deep grey matter. Eur J Radiol 133:109394. https:\/\/doi.org\/10.1016\/j.ejrad.2020.109394","journal-title":"Eur J Radiol"},{"issue":"6","key":"2352_CR33","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1590\/s0004-282x2010000600020","volume":"68","author":"OGP Barsottini","year":"2010","unstructured":"Barsottini OGP, Fel\u00edcio AC, de Aquino CCH, Pedroso JL (2010) Progressive supranuclear palsy: new concepts. Arq Neuropsiquiatr 68(6):938\u2013946. https:\/\/doi.org\/10.1590\/s0004-282x2010000600020","journal-title":"Arq Neuropsiquiatr"},{"key":"2352_CR34","doi-asserted-by":"publisher","first-page":"116443","DOI":"10.1016\/j.jns.2019.116443","volume":"406","author":"M Azuma","year":"2019","unstructured":"Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M et al (2019) Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson\u2019s disease. J Neurol Sci 406:116443. https:\/\/doi.org\/10.1016\/j.jns.2019.116443","journal-title":"J Neurol Sci"},{"issue":"11","key":"2352_CR35","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.21037\/qims-20-285","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Cai T, Li Y, Chi J, Rong S, He C et al (2020) Different iron deposition patterns in Parkinson\u2019s disease subtypes: a quantitative susceptibility mapping study. Quant Imaging Med Surg 10(11):2168\u20132176. https:\/\/doi.org\/10.21037\/qims-20-285","journal-title":"Quant Imaging Med Surg"},{"issue":"5","key":"2352_CR36","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/jmri.25434","volume":"45","author":"X Guan","year":"2017","unstructured":"Guan X, Xuan M, Gu Q, Xu X, Huang P, Wang N et al (2017) Influence of regional iron on the motor impairments of Parkinson\u2019s disease: a quantitative susceptibility mapping study. J Magn Reson Imaging 45(5):1335\u20131342. https:\/\/doi.org\/10.1002\/jmri.25434","journal-title":"J Magn Reson Imaging"},{"key":"2352_CR37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2017.08.013","volume":"44","author":"M Xuan","year":"2017","unstructured":"Xuan M, Guan X, Gu Q, Shen Z, Yu X, Qiu T et al (2017) Different iron deposition patterns in early-and middle-late-onset Parkinson\u2019s disease. Parkinsonism Relat Disord 44:23\u201327. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.013","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2352_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/jon.12957","volume":"32","author":"KR Li","year":"2022","unstructured":"Li KR, Avecillas-Chasin J, Nguyen TD, Gillen KM, Dimov A, Chang E et al (2022) Quantitative evaluation of brain iron accumulation in different stages of Parkinson\u2019s disease. J Neuroimaging 32(2):363\u2013371. https:\/\/doi.org\/10.1111\/jon.12957","journal-title":"J Neuroimaging"},{"issue":"1","key":"2352_CR39","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1471-4159.1958.tb12607.x","volume":"3","author":"B Hallgren","year":"1958","unstructured":"Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3(1):41\u201351. https:\/\/doi.org\/10.1111\/j.1471-4159.1958.tb12607.x","journal-title":"J Neurochem"},{"issue":"1","key":"2352_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jtemb.2013.08.001","volume":"28","author":"P Ramos","year":"2014","unstructured":"Ramos P, Santos A, Pinto NR, Mendes R, Magalh\u00e3es T, Almeida A (2014) Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J Trace Elem Med Biol 28(1):13\u201317. https:\/\/doi.org\/10.1016\/j.jtemb.2013.08.001","journal-title":"J Trace Elem Med Biol"},{"issue":"3","key":"2352_CR41","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.neuroimage.2011.08.077","volume":"59","author":"B Bilgic","year":"2012","unstructured":"Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 59(3):2625\u20132635. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.08.077","journal-title":"Neuroimage"},{"issue":"14","key":"2352_CR42","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1002\/hbm.25569","volume":"42","author":"S Treit","year":"2021","unstructured":"Treit S, Naji N, Seres P, Rickard J, Stolz E, Wilman AH et al (2021) R2* and quantitative susceptibility mapping in deep gray matter of 498 healthy controls from 5 to 90 years. Hum Brain Mapp 42(14):4597\u20134610. https:\/\/doi.org\/10.1002\/hbm.25569","journal-title":"Hum Brain Mapp"},{"issue":"11","key":"2352_CR43","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1002\/hbm.22928","volume":"36","author":"N He","year":"2015","unstructured":"He N, Ling H, Ding B, Huang J, Zhang Y, Zhang Z et al (2015) Region-specific disturbed iron distribution in early idiopathic Parkinson\u2019s disease measured by quantitative susceptibility mapping. Hum Brain Mapp 36(11):4407\u20134420. https:\/\/doi.org\/10.1002\/hbm.22928","journal-title":"Hum Brain Mapp"},{"key":"2352_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2018.01.008","volume":"386","author":"H An","year":"2018","unstructured":"An H, Zeng X, Niu T, Li G, Yang J, Zheng L et al (2018) Quantifying iron deposition within the substantia nigra of Parkinson\u2019s disease by quantitative susceptibility mapping. J Neurol Sci 386:46\u201352. https:\/\/doi.org\/10.1016\/j.jns.2018.01.008","journal-title":"J Neurol Sci"},{"issue":"8","key":"2352_CR45","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/mds.29062","volume":"37","author":"G Du","year":"2022","unstructured":"Du G, Wang E, Sica C, Chen H, De Jesus S, Lewis MM et al (2022) Dynamics of nigral iron accumulation in Parkinson\u2019s disease: from diagnosis to late stage. Mov Disord 37(8):1654\u20131662. https:\/\/doi.org\/10.1002\/mds.29062","journal-title":"Mov Disord"},{"issue":"2","key":"2352_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/mdc3.12130","volume":"2","author":"DA Hall","year":"2015","unstructured":"Hall DA, Forjaz MJ, Golbe LI, Litvan I, Payan CAM, Goetz CG et al (2015) Scales to assess clinical features of progressive supranuclear Palsy: MDS task force report. Mov Disord Clin Pract 2(2):127\u2013134. https:\/\/doi.org\/10.1002\/mdc3.12130","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"2352_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00401-003-0711-4","volume":"106","author":"M Hattori","year":"2003","unstructured":"Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, Hishikawa N, Ueda R et al (2003) Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol (Berl) 106(2):143\u2013149. https:\/\/doi.org\/10.1007\/s00401-003-0711-4","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"2352_CR48","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3174\/ajnr.a4158","volume":"36","author":"M Cosottini","year":"2015","unstructured":"Cosottini M, Frosini D, Pesaresi I, Donatelli G, Cecchi P, Costagli M et al (2015) Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease. Am J Neuroradiol 36(3):461\u2013466. https:\/\/doi.org\/10.3174\/ajnr.a4158","journal-title":"Am J Neuroradiol"},{"key":"2352_CR49","doi-asserted-by":"publisher","first-page":"105383","DOI":"10.1016\/j.clineuro.2019.105383","volume":"183","author":"S Ghourchian","year":"2019","unstructured":"Ghourchian S, Mousavi A, Zamani B, Shahidi G, Rohani M (2019) Midbrain area for differentiating Parkinson\u2019s disease from progressive supranuclear palsy. Clin Neurol Neurosurg 183:105383. https:\/\/doi.org\/10.1016\/j.clineuro.2019.105383","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-023-02352-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-023-02352-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T16:07:06Z","timestamp":1708186026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-023-02352-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,14]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["2352"],"URL":"https:\/\/doi.org\/10.1007\/s13760-023-02352-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,14]]},"assertion":[{"value":"10 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the Institution. The Institutional Ethics Committee, constituted as per national and international standards, reviewed and approved the project before commencement (Ethical approval number SCT\/IEC\/857\/February 2016). Informed consent was obtained from all the participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants gave written informed consent for the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}